US 10813917
Treatment methods utilizing stem cell mobilizers and immunosuppressive agents
granted A61KA61K31/00A61K31/365
Quick answer
US patent 10813917 (Treatment methods utilizing stem cell mobilizers and immunosuppressive agents) held by MedRegen, LLC expires Mon Oct 22 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- MedRegen, LLC
- Grant date
- Tue Oct 27 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 22 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61K, A61K31/00, A61K31/365, A61K31/395, A61K31/436